Cleared Traditional

K213426 - HemosIL ReadiPlasTin (FDA 510(k) Clearance)

Aug 2022
Decision
299d
Days
Class 2
Risk

K213426 is an FDA 510(k) clearance for the HemosIL ReadiPlasTin. This device is classified as a Test, Time, Prothrombin (Class II - Special Controls, product code GJS).

Submitted by Instrumentation Laboratory CO (Bedford, US). The FDA issued a Cleared decision on August 16, 2022, 299 days after receiving the submission on October 21, 2021.

This device falls under the Hematology FDA review panel. Regulated under 21 CFR 864.7750.

Submission Details

510(k) Number K213426 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received October 21, 2021
Decision Date August 16, 2022
Days to Decision 299 days
Submission Type Traditional
Review Panel Hematology (HE)
Summary Summary PDF

Device Classification

Product Code GJS — Test, Time, Prothrombin
Device Class Class II - Special Controls
CFR Regulation 21 CFR 864.7750

Similar Devices — GJS Test, Time, Prothrombin

CoaguChek XS Plus System
K253188 · Roche Diagnostics · Oct 2025
i-STAT PTplus Cartridge with the i-STAT 1 System
K220282 · Abbott Laboratories · Jul 2023
CoaguChek XS Plus System
K180684 · Roche Diagnostics · Apr 2018
CoaguChek XS Pro System
K180693 · Roche Diagnostics · Apr 2018
CoaguChek Vantus System
K170960 · Roche Diagnostics · Dec 2017
Xprecia Stride Coagulation System, Xprecia System PT Controls
K151964 · Siemens Healthcare Diagnostics · Sep 2016